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Background: Anal squamous intraepithelial lesions (SIL) and cancers are increased in immunocompro-
mised populations. Based upon anatomic and histologic similarities, the cervix is used as the model for
anal screening. During cervical colposcopy, acetic acid (AA) and Lugol's staining (LS) result in
characteristic changes that help distinguish low-grade (L)SIL from high-grade (H)SIL. Lesion character-
istics were evaluated for their ability to distinguish anal (a)LSIL from anal (a)HSIL during high-resolution
anoscopy after application of AA and LS.
Methods: AA-stained lesions were described using standard cervical colposcopic criteria. LS was then
applied and lesions were characterized as Lugol's-negative (L), Lugol's-partial (Lþ/), or Lugol's
positive (Lþ) and then biopsied. Biopsies were characterized as benign, squamous atypia, LSIL or HSIL.
Results: 835 anal lesions were analyzed. Sensitivity and positive predictive value (PPV) for aHSIL were
highest for characteristics associated with cervical (c)HSIL. L was independently associated with aHSIL
(OR¼4.7, 95% CI¼3.4–6.7). In multiple logistic regression analysis, signiﬁcant predictors of aHSIL were
ﬂat contour (OR¼2.24, 95% CI¼1.3–3.8), mosaic pattern (OR¼2.0, 95% CI¼1.4–2.9), vascular punctation
(OR¼1.5, 95% CI¼1.1–2.1) and L (OR¼2.3, 95% CI¼1.5–3.4). L staining improved the PPV of aHSIL
almost twofold in lesions that otherwise had a colposcopic impression of LSIL.
Conclusions: Evaluating acetowhite lesions for contour, surface, vascularity, and LS may maximize the
likelihood of identifying aHSIL.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Anal cancer is rare, but the incidence of anal human papillo-
mavirus (HPV) infection, anal low-grade squamous intraepithelial
lesions (LSIL), anal high-grade squamous intraepithelial lesions
(HSIL), and anal cancer are elevated in immune-compromised
populations. In addition, the incidence of anal cancer is increased
among men who have sex with men (MSM) in general, and
women with a history of gynecologic cancers [1–7]. Based on
similarities in the anatomy of the cervix and anal canal, and in the
pathophysiology of HPV-related disease, the cervix has been used
as the model for screening and diagnosis of HPV-induced
abnormalities of the anal canal, including LSIL and HSIL. The same
HPV types affect both cervix and anus [8]. Cervical HSIL and anal
HSIL are considered to be the cancer precursor lesions in the cervix
and anus, respectively [9,10]. Like the anus the cervix is composed
of squamous epithelium adjacent to columnar epithelium in a
transformation zone that undergoes metaplasia. During this
dynamic process, metaplastic squamous cells are susceptible to
transformation by oncogenic HPVs. The majority of cervical HSIL,
anal HSIL and cancers originate in their respective transformation
zones [11–13].
Colposcopic examination is the standard procedure to identify
cervical lesions for biopsy, usually following detection of abnormal
cells on cytology. The colposcope's magniﬁcation and ﬁber-optic
lighting along with application of 3–5% acetic acid and/or Lugol's
staining result in recognizable epithelial and vascular changes or
characteristics associated with cervical SIL that would otherwise
be invisible. The mechanism of action by which acetowhitening
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occurs is incompletely understood but may be caused by light
scattering in dysplastic tissues, osmotic shifts, and/or changes in
cytokeratin expression causing lesions to turn white when acetic
acid applied and can thus be recognized as potentially abnormal
and targeted for biopsy [14,15]. Like acetic acid, Lugol's staining is
used in cervical colposcopy to help differentiate cHSIL from cLSIL
and to determine the lesion margins for treatment. On the cervix,
Lugol's stain is taken up by normal glycogenated squamous
epithelium, inducing a dark mahogany stain. Conversely, abnormal
cells of SIL, particularly those with high-grade morphology, lack
glycogen and thus do not stain [12]
Lesion characteristics, acetowhitening and Lugol's stain pat-
terns are used to guide the selection of cervical biopsy sites to
maximize the likelihood of ﬁnding the most advanced disease,
including cervical HSIL or cervical cancer. Histopathologic assess-
ment of colposcopic-directed biopsies is considered to be the gold
standard for the diagnosis of lesion severity and is used to guide
treatment. Previous work has described the colposcopically-
deﬁned lesion characteristics that help distinguish cervical (c)LSIL
from cervical (c)HSIL [12,13]. Although the sensitivity of cervical
colposcopy to predict the grade of disease varies widely, these
lesion characteristics create a colposcopic impression used to
select lesions to biopsy.
Prior studies have validated the use of anal cytology for screening
of HPV-associated disease of the anus [16–18]. Examination of the
anus with a colposcope, ﬁrst described by O’Connor in 1977 [19] is
now called high resolution anoscopy (HRA). Gradually, HRA has
become essential in diagnosis and management of HPV-associated
anal disease [20,21]. Previous work suggested that the use of acetic
acid and the associated lesion changes characteristic of cervical HSIL
have a sensitivity of 49–61% to detect anal HSIL [22,23]. However, 9–
13% of lesions with colposcopic features consistent with anal LSIL also
contained HSIL on biopsy [22,24]. In the present study, we sought to
describe the lesion characteristics that help to distinguish anal LSIL
from anal HSIL and to determine if the application of Lugol's solution
in addition to acetic acid improved the sensitivity and positive
predictive value (PPV) for anal HSIL compared with acetic acid alone.
2. Methods
We analyzed lesions from 399 HIV-infected and 172 HIV-
uninfected menwho have sex with men (MSM) who were enrolled
in a natural history study of anal SIL between 1998 and 2000, and
who received biopsies during routine bi-annual HRA examina-
tions. Men were recruited via community outreach efforts. Char-
acteristics of this cohort were described previously [17,25].
Excluded from this analysis were 137 HIV-infected and 81 HIV-
uninfected men who were biopsied but had a history of allergy to
iodine and did not receive Lugol's staining, or patients whose
biopsies were scant and could not be interpreted. Patients who
had no anal lesions identiﬁed were not included. Perianal lesions
were excluded because Lugol's staining is not useful on keratinized
epithelium. The Committee on Human Research at the University
of California San Francisco approved this study protocol.
2.1. Procedures
Prior to HRA, the anus was lubricated using 2% lidocaine gel
mixed with KY-jelly while a digital anorectal examwas performed.
A disposable anoscope was then inserted and a Q-tip wrapped in
gauze and soaked in 3% acetic acid was placed in the anus. The
anoscope was removed and the gauze was left in place for at least
one minute to allow the acetic acid to saturate the mucosa of the
entire anal canal. The gauze was then removed and the anoscope
reinserted. HRA was performed with a Zeiss colposcope and
additional acetic acid was liberally applied using small cotton-
tipped swabs to identify colposcopic lesions. Each lesion was
evaluated and coded for the presence or absence of speciﬁc lesion
characteristics using colposcopic criteria commonly used in gyne-
cology and previously validated for anal lesions [22]. Acetowhite
epithelium (AWE) was deﬁned as an area in the anus demarcated
by the application of acetic acid. Each AWE lesion was described
based on speciﬁc characteristics in the following four categories:
contour, surface patterns, vascular patterns and margins. See
Table 1.
Following acetic acid evaluation, full-strength Lugol's solution
(1 part iodine, 2 parts potassium iodide, and 300 parts water) was
applied to each lesion using a Q-tip. Staining patterns were
categorized as Lugol's-negative (L) if no staining occurred,
Lugol's-partial (Lþ/) if staining was variegated in color, or
Lugol's-positive (Lþ) if staining was uniformly dark mahogany
(Fig. 1). Lugol's stain was also applied to the entire transformation
zone of participants who had prior abnormal cytology or history of
aSIL, but no AWE was seen with application of acetic acid during
HRA. The anus was evaluated for the presence of lesions that may
only have been appreciated by Lugol's staining and areas of L
staining were biopsied. These areas of L staining without AWE
were categorized as ‘non-AWE, L lesions’.
In addition, a subset of AWE lesions with different Lugol's staining
patterns within a single AWE lesionwas evaluated from a convenience
series of consecutive biopsies from 25 patients. Distinctly different
areas were biopsied (e.g. one from the L area and one from the Lþ
area) to determine if L staining helped deﬁne the margins of HSIL to
guide treatment. All examinations and biopsies were done by one of
Table 1
Description of lesion characteristics.
Category Characteristic Description
Contour Flat No elevation or minimal thickening, may be irregular or uneven
Raised Exophytic, verrucous, thickened, often in association with papillary changes
Surface patterns Smooth Even, without texture
Granular Irregular, coarse, or gritty
Papillae Thin, ﬁnger-like projections, often with warty looped vessels
Micropapillae Slightly raised projections, similar to papillae but ﬂattened in comparison, small capillary vessels may be present
Vascularity Punctation End-on view of dilated capillary vessels creating dotted pattern, which may be ﬁne or coarse
Mosaic pattern Tile-like pattern of connected vessels, even or uneven, ﬁne or coarse and thickened
Warty vessels Looped capillary vessels often within papillae or Verrucous lesions
Margins Distinct Well-demarcated borders, sharply deﬁned, may have internal margins
Regular Symmetrical, straight or smooth outline
Indistinct Feathery, borders lack clarity
Lugol's stain Negative No iodine uptake, yellow
Partial Variable iodine uptake, speckled appearance of yellow and brown
Complete Mahogany brown coloring, uniform uptake
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two clinicians with 7–10 years experience in HRA at the time (JMB and
NJ). All biopsies were sent for a histologic diagnosis. A single
pathologist provided the histopathology diagnoses, blinded to the
lesion descriptions, clinical impression and patient history. If multiple
levels of SIL were found, the lesions were assigned the diagnosis based
on the highest grade of disease.
2.2. Statistical analysis
Because of the potential bias that might occur with repeated
sampling, only the ﬁrst study visit in which a lesion was biopsied
was included in this analysis. Multiple biopsies from the same patient
were included if they occurred at the same visit and represented
different lesions.
Data were analyzed using SPSS version 15.0 (SPSS, Chicago Ill.).
For analysis, characteristics were dichotomized into categories
hypothesized to be associated with either HSIL or oHSIL (i.e.,
LSIL, squamous atypia or benign). Lugol's staining was dichoto-
mized as L versus Lþ/ or Lþ . Margins were dichotomized as
distinct versus indistinct, or ‘not scored’ since raised lesions were
not given a margin score. Lesions that presented with both
characteristics of a dichotomized variable (for example ﬂat and
raised) were assigned to the category more commonly associated
with LSIL. The dichotomized distribution of histology (HSIL versus
oHSIL) and lesion characteristics were tested for signiﬁcance
using the Chi-square statistic. Sensitivity, speciﬁcity, positive
predictive value (PPV), and negative predictive values (NPV) were
calculated for each characteristic with HSIL as the dependent
variable. To determine whether the addition of Lugol's staining
had improved the performance of each characteristic to predict
HSIL, a variable consisting of the ‘characteristic plus L staining’
was derived in which the positive result (e.g. HSIL) had both the
characteristic and L staining. Contingency tables were calculated
so that true positives were considered to be those characteristics
with L staining and HSIL while false positives were oHSIL. False
negatives consisted of the remaining HSIL that did not have the
characteristic or were not L , and true negatives had neither the
characteristic nor L staining.
An analysis of the most common patterns of characteristics was
done by calculating the frequency of patterns that presented with
combinations of characteristics. All patterns that included at least
10 lesions were included in this analysis. The PPV was estimated as
the proportion of the pattern that had a histologic outcome of HSIL.
Odds ratios (OR) were calculated for each of the characteristics
individually using logistic regression. Multivariable logistic regres-
sion was used to model the cluster of characteristics associated
with HSIL when characteristics had p values of o .05 in the
univariate analyses.
3. Results
A total of 835 lesions representing biopsies taken from 399
HIV-infected and 172 HIV-uninfected men were included in these
analyses. No differences were found in any demographic
A 
B 
C 
Fig. 1. Lugol's staining patterns in anal mucosa. Arrow A indicates positive uptake
of Lugol's with mahogany brown uniform staining. Arrows B indicate partial or
variable Lugol's uptake with areas of dark staining, or light brown uptake. Arrow C
indicates a focal area of Lugol's negative staining
Table 2
Colposcopic characteristics of anal lesions relative to histologic diagnosis.
Characteristic Category Anal HSIL N (%) Anal LSIL N (%) Atypia N (%) Normal N (%) Total N
Acetowhite 389 (47) 349 (42) 43 (5) 54 (6) 835
Contour Flat 327 (60) 143 (26) 35 (6) 45 (8) 550
Raiseda 62 (22) 206 (72) 8 (3) 9 (3) 285
Surface Smooth 374 (48) 322 (41) 42 (5) 49 (6) 787
Not smooth 15 (31) 27 (56) 1 (2) 5 (10) 48
Granular 27 (38) 38 (53) 1 (1) 6 (8) 72
Not granular 362 (47) 311 (41) 42 (6) 48 (6) 763
Papillae 23 (14) 141 (83) 4 (2) 1 (1) 169
No papillae 366 (55) 208(31) 39(6) 54(8) 666
Micropapillae 40 (35) 64 (56) 4 (4) 6 (5) 114
No micropapillae 349 (48) 285 (40) 39 (5) 48 (6) 721
Vascular patterns Punctation 236 (60) 89 (23) 25 (6) 41 (11) 391
No punctation 153 (34) 260 (59) 18 (4) 13( 3) 444
Mosaic pattern 176 (67) 50 (19) 18 (7) 17 (7) 261
No mosaic pattern 213 (37) 299 (52) 25 (4) 37 (6) 574
Warty vessels 61 (23) 189 (71) 8 (3) 7 (3) 265
No warty vessels 328 (58) 160 (28) 35 (6) 47 (8) 570
Margins Distinct 21 (44) 12 (25) 9 (19) 6 (12) 48
Regular 96 (75) 47 (37) 3 (2) 6 (5) 152
Indistinct 232 (58) 105 (26) 28 (7) 35 (9) 400
Not scoredb 40 (17) 185 (79) 3 (1) 7 (3) 235
Lugol's staining Negative 335 (57) 175 (30) 40 (7) 38 (6) 588
Partial 51 (24) 145 (68) 2 (1) 14 (7) 212
Positive 3 (9) 29 (83) 1 (3) 2 (6) 35
Total 389 349 43 54 835
a Includes 48 lesions that were both ﬂat and raised.
b Raised lesions were not scored for margins.
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characteristics between the men enrolled in the cohort study who
did and did not undergo biopsy or whose biopsy results were
excluded. A larger percentage of HIV-infected men (98%) was
biopsied than HIV-uninfected men (92%)
3.1. Anal lesion characteristics
The distribution of lesion characteristics and Lugol's staining
patterns in relationship to histology are listed in Table 2. The
percentages of lesions diagnosed as HSIL (47%) and LSIL (42%)
were similar. The low number of lesions diagnosed as squamous
atypia (5%) and normal (6%) was congruent with the overall study
goal to biopsy areas with an abnormal colposcopic appearance to
determine the incidence of aSIL. Signiﬁcant differences between
lesions diagnosed with HSIL and oHSIL were found for all lesion
characteristics (po .05) except margins and surface granularity.
HSIL was associated with the following characteristics: ﬂat con-
tour, smooth surface, punctation or mosaic pattern, and L
staining. In contrast, characteristics associated with LSIL were
raised contour, granular, papillae or micropapillae surfaces, warty
vessels and Lþ/ or Lþ staining.
All margin characteristics were found more frequently with
HSIL but no single margin characteristic was signiﬁcantly asso-
ciated with a speciﬁc histologic diagnosis. Indistinct margins were
found in 70% of all lesions. Thirty-one percent of lesions were not
scored for margins because they had a raised contour, and these
were mostly LSIL (Table 2).
For all histologic diagnoses, the majority of lesions were L .
However, among the L lesions, 57% of the lesions were diag-
nosed as HSIL, compared with 30% diagnosed as LSIL. In contrast,
among the Lþ/ lesions 24% were HSIL compared with 68%
diagnosed LSIL. Among the Lþ lesions, 8.6% were HSIL compared
with 83% diagnosed with LSIL (Table 2).
3.2. Sensitivity, speciﬁcity and predictive value of lesion
characteristics and Lugol's staining for anal HSIL and LSIL
Characteristics with the highest sensitivities for HSIL were ﬂat,
smooth, punctation, and L staining (Table 3). While having the
highest sensitivity the surface characteristic ‘smooth’ also had the
lowest speciﬁcity and a higher NPV than PPV, indicating that it
was not able to discriminate between HSIL and LSIL. Margins also
were a poor predictor of histologic result. The sensitivity of
L staining for HSIL was 86% and the speciﬁcity was 43%.
The characteristics with the highest sensitivity for LSIL were
raised, smooth, and warty vessels. The sensitivity of Lþ/ staining
for LSIL was 50% and the speciﬁcity of Lþ/ staining for LSIL was
95%. The PPV for HSIL are summarized in Fig. 2. The characteristics
with the highest PPV for HSIL were ﬂat, punctation, mosaic pattern
and L staining. The characteristics with the highest PPV for LSIL
were raised papillae, wart vessels and Lþ/ (data not shown). The
NPV of L staining for HSIL was 78% and the NPV of Lþ/ for LSIL
was 70%. When Lugol's staining was negative, the PPV for HSIL
increased for all characteristics. Characteristics with the highest
PPV for HSIL when also L stained were AWE, ﬂat, smooth,
punctuation, and mosaic pattern (Fig. 2). However the character-
istics with the largest increases in PPV when also L stained were
those typically associated with LSIL (e.g. raised, papillae and warty
vessels). The NPV decreased for those characteristics typically
associated with HSIL while it increased for those typically asso-
ciated with LSIL when L staining was present. The characteristics
with the highest PPV for LSIL were raised, papillae, warty vessels
and Lþ/ staining. The speciﬁcity and NPV of Lþ/ and Lþ for
LSIL were 86% and 70% respectively.
3.3. Logistic regression analyses
The results of the univariate logistic regression analyses indi-
cating the relationships between lesion characteristics and HSIL
are shown in Table 4. Flat contour, punctation, mosaic pattern,
smooth surface, and L were all signiﬁcantly associated with HSIL
(po .0001). Warty vessels, papillae and micropapillae were asso-
ciated with reduced risk of HSIL (po .05). A smooth surface was
associated with HSIL but was not statistically signiﬁcant, and both
granular surface and margins were protective of HSIL but were not
statistically signiﬁcant. A multiple logistic regression analysis that
included all variables is shown in Table 5a. The characteristics that
remained signiﬁcant were ﬂat, punctation, mosaic pattern, distinct
margin, and L . A ﬁnal multiple logistic regression analysis with
variables that remained signiﬁcant is shown in Table 5b and it is
considered the parsimonious model of lesion characteristics asso-
ciated with HSIL.
3.4. Combinations of lesion characteristics
Most anal lesions present in a combination of characteristics.
Patterns were determined using a matrix analysis of all possible
combinations of characteristics. Of the 835 lesions, 720 presented
in 10 patterns with a minimum of 10 lesions per pattern (Table 6).
The highest PPVs (67–68%) for HSIL were in patterns that included
a ﬂat contour, mosaic pattern, and smooth surface with or without
vascular punctation (Fig. 3a and b). The PPV for HSIL for all lesion
patterns increased when L . But lesions with characteristics
typically associated with LSIL such as raised contour, smooth
Table 3
Sensitivity and speciﬁcity of lesion characteristics for anal HSIL and LSIL.
Characteristic Sensitivity Speciﬁcity
Contour LSIL HSIL LSIL HSIL
Flat 45.8 84.1 9.9 50.0
Raised 59.0 15.9 83.7 50.0
Surface
Smooth 92.2 96.1 4.3 7.4
Granular 10.9 6.9 93.0 89.9
Papillae 40.4 5.9 94.2 67.3
Micropapillae 18.3 10.3 89.7 83.4
Vessels
Punctation 24.1 60.7 36.8 65.2
Mosaic pattern 14.3 45.2 56.6 80.9
Warty 52.7 15.7 83.3 54.3
Margins
Distinct 13.5 5.4 78.4 93.9
Indistinct 30.1 59.6 39.3 62.3
Lugol's
Negative 50.1 86.1 15.0 43.3
Pos./Partial 55.3 13.9 88.9 56.7
Fig. 2. The positive predictive value of lesion characteristics before and after
Lugol's staining.
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surface, warty vessels, and papillae or micropapillae had two-to-
threefold increases in the PPV for HSIL when L was present. Only
14% of these lesions were HSIL while 29% of those with L
were HSIL.
3.5. Lugol's staining in the absence of AWE
When there were no acetowhite lesions seen during HRA,
Lugol's staining of the transformation zone was done when a
patient was considered at high-risk for aSIL (e.g. HIV-infected
MSM or previous treatment for HSIL), or had a history of aSIL on
prior anal cytology. 92 biopsies of these non-acetowhite L
stained areas were obtained from 92 patients. While the majority
of these biopsies were normal (40%) or atypical (20%), 19% were
HSIL and 21% were LSIL. These lesions were only visible with L
staining.
3.6. Lugol's staining to deﬁne the borders of a lesion
25 lesions were biopsied to determine whether Lugol's staining
deﬁned the borders for acetowhite lesions with indistinct margins.
In these areas of L staining, the L lesions were biopsied as well
as the adjacent Lþ/ or Lþ stained areas. 76% of the L areas
were HSIL while 12% of the Lþ/ or Lþ were HSIL. Of the 24% L
areas that were not HSIL, 4 were normal and only 2 were LSIL.
None were adjacent to HSIL in the Lþ/ or Lþ areas. Of the
lesions that were Lþ/ and were HSIL, all 3 were adjacent to HSIL
in the adjacent L stained areas.
4. Discussion
This study demonstrates that the colposcopic criteria used to
distinguish cLSIL from cervical HSIL may also be used to distin-
guish between analLSIL and HSIL. The anal transformation zone
and AWE lesions were discernible after application of 3% acetic
acid to the anus. The colposcopic characteristics commonly used to
describe cervical lesions were visible in anal lesions and most
were associated with the expected histopathologic grade. Lugol's
staining distinguished HSIL from LSIL, and helped deﬁne lesion
borders, similar to its utility in detection of cervical disease. Lugol's
staining has also been found to be useful for detection of
esophageal disease [26–28].
Colposcopic detection of anal lesions has been reported by
several groups [16,19,22,29,30]. O’Connor ﬁrst described the use of
the colposcope for detection of anal disease and used acetic acid
minimally but did not use Lugol's solution [19]. Others have used
the colposcope with acetic acid [29] or modiﬁed colposcopic
terminology [24,30]. In one study the colposcopic appearance of
a lesion was not predictive of histology, but lesions were categor-
ized only by contour [30]. Scholeﬁeld et al. [24] reported correla-
tions between colposcopic features and histology in 213 women
but used a histologic classiﬁcation system different from current
standards. Friedlander et al. [16] used HRA in 32 patients and
reported an 81% correlation between HRA impression and histol-
ogy but did not report the criteria used for colposcopic impression.
A recent study adapted vulvar terminology and found similar PPV
for combinations of these adapted lesion characteristics including
L staining in a series of 168 lesions [31]. In the largest study to
date of 385 biopsied anal lesions from 152 men, the colposcopic
appearance of anal lesions was shown to be similar to cervical
lesions and correlated with expected grade of disease but did not
include Lugol's staining [22]. The current study represents the
largest series of patients and lesions described, biopsied, and
correlated with histologic diagnoses using standard colposcopy
techniques including acetic acid and Lugol's staining.
Characteristics in four of ﬁve categories (i.e., contour, surface,
vascular patterns, and Lugol's staining) were found to broadly
distinguish between LSIL and HSIL. Those associated with cHSIL:
ﬂat contour, smooth surface, punctation or mosaic vessels, and L
staining were all associated with HSIL both as individual char-
acteristics and in combinations of characteristics. However,
‘smooth’ did not remain signiﬁcant in the multivariable logistic
regression. Characteristics associated with cLSIL: raised contour,
granular, papillae and micropapillae surfaces, warty vessels, and LP
or Lþ staining were all associated with LSIL.
The PPV for HSIL of all characteristics increased with a L stain
pattern. Importantly, the largest increases were found in L
staining of lesions with otherwise typical LSIL appearances (see
Fig. 4a and b). Prior studies have noted that approximately 10% of
Table 4
Univariate logistic regression analysis of anal lesion characteristic's ability to
predict anal HSIL.
Characteristic Odds ratio 95% Conﬁdence limit p Value
Low High
Contour
Flat 5.27 3.80 7.32 o .0001
Vessels
Mosaic pattern 3.51 2.58 4.78 o .0001
Punctation 2.90 2.19 3.84 o .0001
Warty vessels .22 .16 .31 o .0001
Surface
Smooth 1.99 1.07 3.73 .0310
Granular .67 .40 1.09 .11
Papillae .13 .08 .21 o .0001
Micropapillae .58 .39 .87 .0086
Margins
Distinct .89 .49 1.59 .68
Lugol's negative 4.73 3.36 6.67 o .0001
Table 5a
Multiple logistic regression analysis of anal lesion characteristics ability to predict
HSIL.
Characteristic Odds ratio 95% Conﬁdence limit p Value
Low High
Contour
Flat 2.24 1.32 3.79 .003
Vessels
Mosaic pattern 2.03 1.43 2.88 o .0001
Punctation 1.53 1.07 2.06 .019
Warty vessels 1.07 .56 2.06 .83
Surface
Smooth 1.77 .59 5.31 .30
Granular 1.91 .74 4.88 .18
Papillae .55 .25 1.21 .14
Micropapillae .94 .51 1.74 .84
Margins
Distinct .43 .22 .82 .010
Lugol's negative 2.27 1.52 3.40 o .0001
Table 5b
Final logistic regression model for anal characteristics predictive of HSIL.
Characteristic Odds ratio 95% Conﬁdence limit p Value
Low High
Flat 2.75 1.89 3.99 o .0001
Mosaic pattern 2.01 1.44 2.81 o .0001
Punctation 1.47 1.06 2.03 .0200
Lugol's Negative 2.32 1.57 3.42 o .0001
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lesions with an LSIL appearance were HSIL [22,24]. In this series,
14% of lesions with LSIL characteristics were found to be HSIL on
histology. However, this increased to 25% when L compared with
only 10% of the Lþ or L þ/ lesions. The PPV for HSIL was
approximately two-fold higher when individual characteristics
usually associated with LSIL were also L . Findings from this
study suggest that the addition of Lugol's staining to the HRA may
help to differentiate HSIL lesions from LSIL with more precision
than reliance upon the lesion's acetic acid appearance alone.
Speciﬁcally, lesions with a low-grade colposcopic impression
should be considered for biopsy if that lesion is also L .
Margin characteristics were not associated with the histologic
grade of disease; this differs from cervical colposcopy. Cervical
lesion margins are readily appreciated with the application of
acetic acid, while anal lesion margins were difﬁcult to evaluate
and were frequently obscured or not fully seen. Since raised
lesions, which were mostly LSIL, were not coded for margins in
this study, this resulted in a falsely-inﬂated association between all
Table 6
Combination of common lesion patterns: positive predictive value and logistic regression predictive probability for anal HSIL.
Pattern Pattern
Total N
# HSIL in
pattern
PPV (%) Lugol's-negative Logistic
regression of
patterns when
Lugol's-negative
Pattern
Total N
# HSIL in
pattern
PPV (%)
AWEa, ﬂat, mosaic, smooth 88 60 68 75 53 71 .671
AWE, ﬂat, mosaic, punctation, smooth 144 97 67 137 92 67 .757
AWE, ﬂat, punctation, smooth 184 105 57 157 93 59 .606
AWE, ﬂat, smooth 69 35 51 58 31 53 .502
AWE, ﬂat, warty vessels, smooth 11 4 36 6 3 50 .519
AWE, ﬂat, warty vessels, smooth, micropapillae 32 11 34 15 6 40 .503
AWE. raised, warty vessels, smooth, micropapillae 18 6 33 10 5 50 .311
AWE, raised, warty vessels, smooth, papillae 138 18 13 32 7 22 .209
AWE, raised, granular 20 2 10 10 1 10 .326
AWE, raised, warty vessels, smooth, papillae, micropapillae 16 0 0 1 0 0 .134
Total lesions with o5 lesions per pattern 116 45 39 76 35 46 NA
a AWE, acetowhite epithelium.
Fig. 3. (A) and (B): an HSIL AWE lesion with coarse mosaic pattern and Lugol's
negative staining.
A 
A 
B
B
Fig. 4. (A) and (B): AWE lesions with raised warty pattern: In (a) lesions are seen
prior to Lugol's staining. In (b) the same lesions are shown after Lugol's staining.
Biopsied areas are indicated by arrows. Arrow A indicates a Lugol's negative stained
area that was HSIL. Arrow B indicates area with Lugol's-positive/partial staining
that was LSIL.
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of the margin characteristics and HSIL. In some cases, the addition
of LS allowed the clinician to see distinct margins when only
indistinct margins were seen with acetic acid. In these situations
Lugol's staining, may help deﬁne lesion margin for ablative
treatment. Further research is needed to determine whether lesion
margins in the anus can be better deﬁned using Lugol's staining in
addition to acetic acid.
While it is relatively easy to deﬁne the different Lugol's staining
patterns, Lugol's staining alone is not adequate for determining
sites for biopsy. The low speciﬁcity (43%) and PPV (57%) for HSIL
are not unique to anal lesions and have been seen with cervical
and esophageal lesions [32–34]. It is therefore emphasized that a
L appearance cannot be the sole criterion for discriminating
between potential LSIL and HSIL. In addition to the observation
that LSIL commonly shows L staining, several other situations
can cause the anal mucosa to have a L stain in the absence of
HSIL. Glycogen is absent in scar tissue and in normal columnar
epithelium and immature squamous metaplasia. Verrucous LSIL
may appear to be L if the stain is not applied carefully to the
uneven surface and this may have contributed to a higher than
expected rate of L staining in the absence of HSIL. The distal
canal and perianus will also appear L as keratinized epithelium
is not heavily glycogenated. Familiarization with these features
will improve the PPV but even very skilled clinicians will obtain
biopsies of L lesions that are not HSIL.
In some cases Lugol's staining but not acetic acid revealed the
presence of lesions. Biopsies of these L stained areas yielded
additional HSIL (19%) or LSIL (21%) in 92 lesions that may not have
otherwise been biopsied. These ﬁndings suggest that L staining
may help identify HSIL when no acetowhite lesions are identiﬁed
on HRA in high-risk situations such as after HSIL cytology.
Visual inspection of the cervix using Lugol's staining has been
used in low resource settings in the absence of colposcopy. The
sensitivity for cHSIL ranged from 60% to 87% while speciﬁcity
ranged from 63% to 88% in these studies [35–37]. In this study, the
sensitivity to detect HSIL was similar at 86% although speciﬁcity
was lower (43%). However, the high NPV (78%) of L for HSIL and
the high PPV of Lþ/ or Lþ for LSIL (75%) were notable. Only 14%
of HSIL lesions were Lþ/ or Lþ , indicating that in the absence of
other criteria, an Lþ/ or Lþ lesion is unlikely to be HSIL.
There were several limitations in this study. Compared with prior
published results [22] the higher prevalence of HSIL in this series
may indicate an increased prevalence of HSIL in this cohort or that
the clinicians became more skilled at distinguishing HSIL from LSIL.
The high PPVs of lesion characteristics and combinations reported in
this series may reﬂect the high proportion of the study population
that was diagnosed with HSIL and the results may not be general-
izable. However, the logistic regression analyses, a statistic less
inﬂuenced by prevalence, indicated that the characteristics hypothe-
sized to be associated with HSIL were signiﬁcant indicators for HSIL
and may be applicable even in a population with lower prevalence of
HSIL. Our results may also not be generalizable to less experienced
clinicians, as our own data indicated higher sensitivities and PPV in
the lesions evaluated by more experienced clinicians (data not
shown). The exclusion of scant biopsies or those in which Lugol's
staining was not done may have introduced bias to the analysis.
Finally, in this study 3% rather than 5% acetic acid was used and may
have adversely affected lesion identiﬁcation. The preponderance of
L lesions revealed a sampling bias. Systematic biopsies of Lþ or
LPþ/ and L areas could decrease sampling bias.
5. Conclusions
Colposcopic examination is considered standard practice to
identify cervical SIL or cancer following an abnormal screening
cervical cytology. Application of acetic acid, evaluation of the
lesion for different characteristics, and Lugol's staining are com-
monly used in gynecology to guide the clinician's choice for
biopsy. Lugol's staining is routinely used to determine the margins
for excision and treatment of HSIL in the cervix as well as the
esophagus. This study represents the largest series of anal lesion
descriptors with corresponding histology as well as the ﬁrst
systematic examination of Lugol's staining in anal lesions. The
results indicate that colposcopic criteria developed for the cervix
are useful to distinguish high-grade from low-grade anal lesions.
Patients with abnormal anal cytology may present with a large
volume of disease and with varying types of lesions. It is not
possible to biopsy every lesion. Clinicians must choose the lesions
most likely to provide the highest grade of histopathology. A better
understanding of the appearance and characteristics of these
lesions will maximize the likelihood of obtaining the highest-
grade lesions. Because clinicians typically assume that a lesion
with warty appearance is LSIL, these are frequently not biopsied
and may not be treated. These ﬁndings underscore the importance
of biopsying lesions even when HSIL is not suspected. It has
particular importance when cytology indicates the presence of
HSIL but the lesions all have the appearance of LSIL. L staining in
these circumstances may provide the means to distinguish addi-
tional HSIL from LSIL when a lesion appears to be LSIL prior to
application of Lugol's solution.
Evaluating lesions systematically for their contour, surface,
vascular patterns and Lugol's staining can help guide the clinician
in choosing lesions for biopsy to submit for histologic diagnosis. In
particular, acetowhite lesions presenting with a pattern that
includes punctation and mosaic vascular patterns and L staining
are likely to indicate the presence of HSIL. Standardization of HRA
techniques including application of acetic acid and Lugol's staining
may help maximize the likelihood of ﬁnding HSIL for diagnosis
and treatment.
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